Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingke granules for pediatric acute bronchitis (phlegm-heat obstructing the lung) – Phase III RCT
CTR20263068Phase 3Active
- Sponsor
- Yiling Pharmaceutical
- Start
- Aug 2026
- Countries
- 1
01
Overview
A Phase 3 trial of Lianhua Qingke Granules in acute bronchitis, sponsored by Yiling Pharmaceutical. Started Aug 2026; status: active.
02
Drugs
Lianhua Qingke Granules
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on CTR20263068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263068.